Tracleer in Behçet's disease

• Conditions: Behç et's diseasebosentanvasculitisendothelin 1

• Registration Number: NL-OMON26435
• Lead Sponsor: ErasmusMC

Brief Summary

/A

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 28 February 2024

Recruitment & Eligibility

• Status: Pending
• Sex: Not specified
• Target Recruitment: 20

Inclusion Criteria

1. BD patients classified according to the criteria according to the International study group for BD

2.BD patients not responding to their usual therapy (BDCAF > 20)

Exclusion Criteria

1.Age < 18 years.

2.Women who are pregnant, nursing, or planning pregnancy within 38 weeks after enrollment.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
- A decrease in the score in the BDCAF of > 10 in patients with BD with a BDCAF score of > 20

Secondary Outcome Measures

Name	Time	Method
- ET-1 levels in relation with BDCAF.<br /><br>- Study of cytokine patterns in relation with therapy and BDCAF.<br /><br>- T cell patterns in relation with therapy and BDCAF.<br>